These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 38473905)

  • 21. Cardiorenal syndrome type 1: pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure.
    Ronco C; Cicoira M; McCullough PA
    J Am Coll Cardiol; 2012 Sep; 60(12):1031-42. PubMed ID: 22840531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Target organ cross talk in cardiorenal syndrome: animal models.
    Bongartz LG; Braam B; Gaillard CA; Cramer MJ; Goldschmeding R; Verhaar MC; Doevendans PA; Joles JA
    Am J Physiol Renal Physiol; 2012 Nov; 303(9):F1253-63. PubMed ID: 22914779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heart Disease and the Kidneys.
    Silva RP; Diógenes C
    Contrib Nephrol; 2021; 199():71-79. PubMed ID: 34428764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiorenal Syndrome in End-Stage Kidney Disease.
    Tsuruya K; Eriguchi M; Yamada S; Hirakata H; Kitazono T
    Blood Purif; 2015; 40(4):337-43. PubMed ID: 26657922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurohormonal, Endocrine, and Immune Dysregulation and Inflammation in Cardiorenal Syndrome.
    Clementi A; Virzì GM; Battaglia GG; Ronco C
    Cardiorenal Med; 2019; 9(5):265-273. PubMed ID: 31266023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Bidirectional Association of Chronic Kidney Disease, Type 2 Diabetes, Atherosclerotic Cardiovascular Disease, and Heart Failure: The Cardio-Renal-Metabolic Syndrome.
    Nichols GA; Amitay EL; Chatterjee S; Steubl D
    Metab Syndr Relat Disord; 2023 Jun; 21(5):261-266. PubMed ID: 37130317
    [No Abstract]   [Full Text] [Related]  

  • 27. Type 4 cardiorenal syndrome.
    Pinheiro da Silva AL; Vaz da Silva MJ
    Rev Port Cardiol; 2016 Nov; 35(11):601-616. PubMed ID: 27712930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardio-renal syndrome type 4: epidemiology, pathophysiology and treatment.
    House AA
    Semin Nephrol; 2012 Jan; 32(1):40-8. PubMed ID: 22365161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiorenal syndrome in chronic kidney disease.
    Tsuruya K; Eriguchi M
    Curr Opin Nephrol Hypertens; 2015 Mar; 24(2):154-62. PubMed ID: 25636143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathophysiology of cardiorenal syndrome type 2 in stable chronic heart failure: workgroup statements from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI).
    Cruz DN; Schmidt-Ott KM; Vescovo G; House AA; Kellum JA; Ronco C; McCullough PA
    Contrib Nephrol; 2013; 182():117-36. PubMed ID: 23689659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular pathways and crosstalk characterizing the cardiorenal syndrome.
    Mühlberger I; Mönks K; Fechete R; Mayer G; Oberbauer R; Mayer B; Perco P
    OMICS; 2012 Mar; 16(3):105-12. PubMed ID: 22401656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardio-Renal Syndrome Type 4: The Correlation Between Cardiorenal Ultrasound Parameters.
    Lai S; Ciccariello M; Dimko M; Galani A; Lucci S; Cianci R; Mariotti A
    Kidney Blood Press Res; 2016; 41(5):654-662. PubMed ID: 27665506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RAAS inhibition and cardiorenal syndrome.
    Onuigbo MA
    Curr Hypertens Rev; 2014; 10(2):107-11. PubMed ID: 25549841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiorenal syndrome in heart failure with preserved ejection fraction-an under-recognized clinical entity.
    Agrawal A; Naranjo M; Kanjanahattakij N; Rangaswami J; Gupta S
    Heart Fail Rev; 2019 Jul; 24(4):421-437. PubMed ID: 31127482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [INTERRELATIONS BETWEEN MICROALBUMINURIA AND RENAL FUNCTION WITH CONTRACTILE ABILITY OF LEFT VENTRICLE IN CARDIORENAL SYNDROME PATIENTS].
    Minasyan A; Gareginyan N
    Georgian Med News; 2015 Oct; (247):34-8. PubMed ID: 26483371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cardiorenal syndrome: pathophysiologic crosstalk, outcomes, and treatment targets.
    Cohen L
    Cardiovasc Hematol Disord Drug Targets; 2014; 14(3):170-6. PubMed ID: 24993122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathophysiology of the cardio-renal syndromes types 1-5: An uptodate.
    Di Lullo L; Bellasi A; Barbera V; Russo D; Russo L; Di Iorio B; Cozzolino M; Ronco C
    Indian Heart J; 2017; 69(2):255-265. PubMed ID: 28460776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiorenal syndrome.
    Ronco C; Haapio M; House AA; Anavekar N; Bellomo R
    J Am Coll Cardiol; 2008 Nov; 52(19):1527-39. PubMed ID: 19007588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiorenal Syndrome: New Pathways and Novel Biomarkers.
    Gembillo G; Visconti L; Giusti MA; Siligato R; Gallo A; Santoro D; Mattina A
    Biomolecules; 2021 Oct; 11(11):. PubMed ID: 34827580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options.
    Jankowski J; Floege J; Fliser D; Böhm M; Marx N
    Circulation; 2021 Mar; 143(11):1157-1172. PubMed ID: 33720773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.